Article
FDA expands use of remdesivir to patients with high risk of hospitalization
Rating:
0.0
Views:
73
Likes:
1
Library:
1
The U.S. health regulator on Friday expanded its approval for the use of Gilead Sciences' antiviral drug remdesivir to treat non-hospitalized patients 12 years and older for the treatment of mild-to-moderate COVID-19 disease with high risk of hospitalization.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value